Kitagawa, Noriyuki
Ushigome, Emi
Matsumoto, Shinobu
Oyabu, Chikako
Ushigome, Hidetaka
Yokota, Isao
Asano, Mai
Tanaka, Muhei
Yamazaki, Masahiro
Fukui, Michiaki
Article History
Received: 10 May 2017
Revised: 13 September 2017
Accepted: 31 October 2017
First Online: 14 March 2018
Compilance with ethical standards
:
: NK, EU, SM, CO, MT, MY, and MF have received grant and research support from AstraZeneca plc, Astellas Pharma Inc., Bristol-Myers Squibb K.K., Daiichi Sankyo Co., Ltd., Eli Lilly Japan K.K., Kyowa Hakko Kirin Company Ltd., Kowa Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., MSD K.K., Mitsubishi Tanabe Pharma Corp., Novo Nordisk Pharma Ltd., Nippon Chemiphar Company Ltd., Sanwa Kagaku Kenkyusho Co., Ltd., Sanofi K.K., Taisho Toyama Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., and TERUMO Co. The remaining authors declare no conflict of interest.